We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
(+8.9%)
Cap. Flow
+$2.05B
Cap. Flow
% of AUM
8.49%
Top 10 Holdings %
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$127M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$126M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$122M |
| 4 |
SkinHealth Systems
SKIN
|
+$90.5M |
| 5 |
Advanced Micro Devices
AMD
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$210M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$187M |
| 3 |
XYZ
Block Inc
XYZ
|
+$111M |
| 4 |
Danaher
DHR
|
+$109M |
| 5 |
Monster Beverage
MNST
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.28% |
| 2 | Financials | 16.56% |
| 3 | Technology | 13.74% |
| 4 | Consumer Discretionary | 11.01% |
| 5 | Communication Services | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSFG
2676
DELISTED
First Savings Financial Group
FSFG
| $274K | ﹤0.01% |
+9,732
| New | +$259K |
|
2677
Covenant Logistics
CVLG
$1.04B
| $273K | ﹤0.01% |
+19,720
| New | +$221K |
|
2678
Orthofix Medical
OFIX
$492M
| $273K | ﹤0.01% |
+7,170
| New | +$285K |
|
2679
CALL
UnitedHealth
UNH
$382B
| $273K | ﹤0.01% |
+700
| New | +$290K |
|
|
EVLO
2680
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $273K | ﹤0.01% |
1,940
-1,190
| -38% | -$236K |
|
2681
Home Bancorp
HBCP
$558M
| $271K | ﹤0.01% |
+7,013
| New | +$261K |
|
2682
PUT
Caterpillar
CAT
$361B
| $269K | ﹤0.01% |
+1,400
| New | +$292K |
|
2683
Johnson Controls International
JCI
$85.1B
| $269K | ﹤0.01% |
3,954
-744
| -16% | -$53.7K |
|
2684
PUT
Avis
CAR
$5.47B
| $268K | ﹤0.01% |
+2,300
| New | +$203K |
|
2685
Phibro Animal Health
PAHC
$1.5B
| $268K | ﹤0.01% |
12,455
-8,184
| -40% | -$197K |
|
2686
International Bancshares
IBOC
$4.77B
| $267K | ﹤0.01% |
+6,412
| New | +$262K |
|
2687
TransDigm Group
TDG
$70.7B
| $267K | ﹤0.01% |
+427
| New | +$267K |
|
|
DVLT
2688
Datavault AI
DVLT
$279M
| $267K | ﹤0.01% |
6
-1
| -14% | -$50K |
|
|
SMAR
2689
DELISTED
Smartsheet Inc.
SMAR
| $267K | ﹤0.01% |
3,876
-29,809
| -88% | -$2.19M |
|
2690
Invesco S&P 500 Top 50 ETF
XLG
$10.2B
| $265K | ﹤0.01% |
8,030
-780
| -9% | -$26.4K |
|
2691
Amkor Technology
AMKR
$10.6B
| $263K | ﹤0.01% |
+10,528
| New | +$269K |
|
2692
QuickLogic
QUIK
$211M
| $263K | ﹤0.01% |
49,009
-22,266
| -31% | -$126K |
|
|
BNAI
2693
Brand Engagement Network
BNAI
$78.7M
| $263K | ﹤0.01% |
+2,688
| New | +$261K |
|
2694
MidCap Financial Investment
MFIC
$801M
| $261K | ﹤0.01% |
+20,127
| New | +$274K |
|
|
CSII
2695
DELISTED
Cardiovascular Systems, Inc.
CSII
| $261K | ﹤0.01% |
7,958
-1,647
| -17% | -$61.4K |
|
|
BFX
2696
DELISTED
BowFlex Inc.
BFX
| $260K | ﹤0.01% |
27,950
-24,258
| -46% | -$311K |
|
2697
Wolverine World Wide
WWW
$1.68B
| $259K | ﹤0.01% |
8,669
-191,438
| -96% | -$6.53M |
|
2698
VanEck Steel ETF
SLX
$166M
| $257K | ﹤0.01% |
4,646
-33,755
| -88% | -$2.08M |
|
2699
eBay
EBAY
$51.2B
| $255K | ﹤0.01% |
+3,659
| New | +$262K |
|
|
BFIN
2700
DELISTED
BankFinancial
BFIN
| $254K | ﹤0.01% |
+22,123
| New | +$251K |
|
Similar funds
Marshall Wace's Q3 2021 Portfolio in Review
As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.
- Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
- Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
- Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
- Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
- Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
- Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
- Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.
Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.